Anthera Pharmaceuticals, Inc.
OTC: ANTH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Paul F. Truex
- Employees
- 21
- Headquarters
- Houston, United States
- IPO year
- 2010
- Market cap
- $26.2K
- Website
- https://www.anthera.com
Loading ANTH…
Loading profile data…Frequently asked questions about ANTH
What does Anthera Pharmaceuticals, Inc. (ANTH) do?
Anthera Pharmaceuticals, Inc., a biopharmaceutical enterprise, concentrates on developing and commercializing therapeutic solutions for conditions with significant unmet medical needs. The company's pipeline includes Sollpura, an investigational non-porcine pancreatic enzyme replacement therapy in Phase III clinical trials for individuals with e...
Where does ANTH trade?
Anthera Pharmaceuticals, Inc. (ANTH) trades on the Other OTC.
What sector is ANTH in?
Anthera Pharmaceuticals, Inc. (ANTH) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Anthera Pharmaceuticals, Inc.?
Paul F. Truex is the chief executive officer of Anthera Pharmaceuticals, Inc. (ANTH).
Where is Anthera Pharmaceuticals, Inc. headquartered?
Anthera Pharmaceuticals, Inc. is headquartered in United States.
Does ANTH pay a dividend?
Anthera Pharmaceuticals, Inc. (ANTH) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ANTH go public?
Anthera Pharmaceuticals, Inc. (ANTH) completed its initial public offering in 2010.